Arrowhead Pharmaceuticals
ARWR
#2176
Rank
$8.49 B
Marketcap
$61.44
Share price
-4.98%
Change (1 day)
160.23%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): -$1.25

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.25. In 2024 the company made an earnings per share (EPS) of -$5.00 a decrease over its 2023 EPS that were of -$1.91.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$1.25-75%
2024-$5.00161.39%
2023-$1.9117.36%
2022-$1.6319.85%
2021-$1.3661.9%
2020-$0.84-216.67%
2019$0.72-210.77%
2018-$0.6538.3%
2017-$0.47-64.93%
2016-$1.34-16.25%
2015-$1.6028%
2014-$1.25-3.85%
2013-$1.30-31.58%
2012-$1.90331.82%
2011-$0.44-51.11%
2010-$0.90-79.07%
2009-$4.30-37.68%
2008-$6.90-16.87%
2007-$8.3038.33%
2006-$6.00122.22%
2005-$2.7042.11%
2004-$1.90533.33%
2003-$0.30-99.08%
2002-$32.4725%
2001-$25.9733.33%
2000-$19.48-120%
1999$97.40-400%
1998-$32.47-81.48%
1997-$175.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Alnylam Pharmaceuticals
ALNY
$0.09000-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$2.39-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-$2.88 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$10.44-935.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-$8.07 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA